FAYETTEVILLE, NY, UNITED STATES, January 9, 2026 /EINPresswire.com/ — January is traditionally a peak period for pharmaceutical list price adjustments. The AnalySource team analyzed Wholesale ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

Sharp Sterile Manufacturing is investing $28 million to expand equipment at its Lee facility, a move expected to double ...

Jan ‌13 (Reuters) - ​Thermo Fisher Scientific's ‌pharmaceutical services business has won a number of ​contracts to help its ...

A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout ...

HRV Pharma’s innovative “virtual manufacturing” model connects FDA-approved facilities to prevent prescription shortages and ...

Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an ...

Drugmakers told the FDA that inflexible post-approval change requirements are among the top regulatory barriers to the ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 1 includes Axsome Therapeutics, Berkshire ...

Turning Any Medication into a Precision AI-Combo Drug through Simple QR-Code Integration LAS VEGAS, NV / ACCESS Newswire / ...

New Hampshire Republican Senate candidate John E. Sununu tried to hide his ties to big pharma in a recent interview on the ...

Now, it’s worth noting Stock Advisor’s total average return is 968 % — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...